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 “Exergy-based Sustainability Assessment of Batch versus Continuous Tabletting in  
Pharmaceutical Formulation” 
This study approaches the environmental sustainability of batch versus continuous granulation-based 
tablet manufacturing from a resource point of view by conducting Exergy Analysis (EA) and Exergetic 
Life Cycle Analysis (ELCA) at three different levels in order to identify and locate resource losses 
through the pharmaceutical production chain. Exergy analysis is performed at both process (α) and 
plant (β) level (Janssen-Cilag NV pharmaceutical manufacturing plant at Latina, Italy), while the 
CEENE method (Cumulative Exergy Extraction from the Natural Environment) is used in a cradle-to-
gate approach at the overall industrial level (γ). Shifting from batch to continuous production 
resulted in an exergetic resource consumption reduction of 10.19% (65.6 to 58.9 kJex/tablet), 15.21% 
(111 to 94.0 kJex/tablet) and 2.38% (2.14 to 2.08 MJex/tablet) at respectively process (α), plant (β) and 
overall industrial level (γ). Focussing on drug production processes by excluding API and packaging 
material constituents (transitting exergy) resulted in a reduction of 33.99% (19.1 to 12.6 kJex/tablet), 
25.89% (64.6 to 47.7 kJex/tablet) and 14.69% (138 to 118 kJex/tablet) on the respective boundary 
systems. The results apply to high dose drugs (high API weight percentage). For low dose drugs (total 
API percentage of less than 50%), sensitivity analysis showed a reduction in resource consumption of 
38% within the cradle-to-gate approach (γ). Extensions to the scope of this study resulted in including 
packaging as well as distribution phases to assess the impact within the total pharmaceutical 
production chain. At γ level, natural resources for packaging materials proved to be dominated by its 
land demand, while natural resources for the API production as well as drug product production 
processes and distribution and transport processes were dominated by fossil resources. From an 
emission point of view, the plant’s carbon Ecological Footprint proved to be reduced by 10.10% (2 
883 to 2 592 ha.a) when shifting the plant’s yearly tablet manufacturing from batch to continuous 
production. 
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